
E135: IL17 and a GLP1?
Apr 30, 2026 - 11:03
Radio and PodcastLive Radio & Podcasts
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me abou...
E126: Risk Signals, JAKs, and SELECTIVE-ity is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially s...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Sep 8, 2025, 14:34 long, audio available.
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published Paper:
You can listen to E126: Risk Signals, JAKs, and SELECTIVE-ity online on Radio and Podcast. Open the player on this page to stream the available audio.
E126: Risk Signals, JAKs, and SELECTIVE-ity is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 14:34 long.
This episode was published on Sep 8, 2025.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E126: Risk Signals, JAKs, and SELECTIVE-ity on this page when the episode audio is available from the podcast feed.
E126: Risk Signals, JAKs, and SELECTIVE-ity is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Sep 8, 2025 and 14:34 long